FDA approves Latitude patient management system upgrade
The FDA has approved Boston Scientific’s Latitude 6.0, a software upgrade to the company's Latitude patient management system.
The system enables physicians to remotely monitor patients with implantable cardiac devices and provides functionality, including the ability to view a history of a patient's remote follow-up data, according to the Natick, Mass.-based health IT company.
According to Boston Scientific, the system can detect changes in a patient's heart health status between scheduled follow-up visits and send relevant data and alerts directly to physicians.
The Latitude patient management system will be demonstrated at Boston Scientific's booth (#1017) during the 31st Annual Scientific Sessions of the Heart Rhythm Society, May 13 - 15 in Denver.
The system enables physicians to remotely monitor patients with implantable cardiac devices and provides functionality, including the ability to view a history of a patient's remote follow-up data, according to the Natick, Mass.-based health IT company.
According to Boston Scientific, the system can detect changes in a patient's heart health status between scheduled follow-up visits and send relevant data and alerts directly to physicians.
The Latitude patient management system will be demonstrated at Boston Scientific's booth (#1017) during the 31st Annual Scientific Sessions of the Heart Rhythm Society, May 13 - 15 in Denver.